Form 13-F position report

CONTEXT THERAPEUTICS INC

Reported by Ally Bridge Group NY LLC

CNTX CUSIP 21077P108 Manager CIK 0001822947

Reported 1,157,448 shares, down 419,314 (26.6%) from the prior quarter.

Reported value -57.2%; share count -26.6% vs. the prior quarter.

Reduced
% of reported 13F value 0.64% This manager · Q1 2025
Shares 1,157,448 Quarter-end amount reported
Reported value $708,358 Fair value at quarter end
Consecutive quarters held 8 Through Q1 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 1045434
2023-09-30 1096186
2023-12-31 820325
2024-03-31 1001812
2024-06-30 3781895
2024-09-30 3444747
2024-12-31 1655600
2025-03-31 708358
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for CONTEXT THERAPEUTICS INC held by Ally Bridge Group NY LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -1,157,448 (-100.0%) 0 $0 2025-08-14
Q1 2025 Reduced 1,157,448 -419,314 (-26.6%) 0.64% $708,358 2025-05-15
Q4 2024 Reduced 1,576,762 -180,762 (-10.3%) 1.42% $1,655,600 2025-02-14
Q3 2024 Reduced 1,757,524 -128,708 (-6.8%) 1.84% $3,444,747 2024-11-14
Q2 2024 Added 1,886,232 +1,160,281 (159.8%) 2.25% $3,781,895 2024-08-14
Q1 2024 Unchanged 725,951 0 (0.0%) 0.56% $1,001,812 2024-05-15
Q4 2023 Unchanged 725,951 0 (0.0%) 0.49% $820,325 2024-02-14
Q3 2023 Added 725,951 +72,555 (11.1%) 1.29% $1,096,186 2023-11-14
Q2 2023 New 653,396 +653,396 (0.0%) 1.27% $1,045,434 2023-08-14

Who else reported the position

55 managers reported CONTEXT THERAPEUTICS INC for Q1 2025.

Managers reporting CONTEXT THERAPEUTICS INC in Q1 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BIOIMPACT CAPITAL LLC Unchanged 14,705,882 0 1.55% $9,000,000 2 qtrs
Avidity Partners Management LP Unchanged 7,477,200 0 0.87% $4,576,046 4 qtrs
Nextech Invest Ltd New 7,419,355 +7,419,355 1.06% $4,540,645 1 qtr
Deep Track Capital LP Unchanged 7,419,355 0 0.15% $4,540,645 4 qtrs
Blue Owl Capital Holdings LP Added 7,367,906 +1,009,978 1.45% $4,509,158 4 qtrs
GREAT POINT PARTNERS LLC Unchanged 4,683,711 0 1.52% $2,866,431 4 qtrs
FRANKLIN RESOURCES INC Unchanged 4,003,380 0 < 0.01% $2,450,069 3 qtrs
VANGUARD GROUP INC Reduced 3,253,467 -1,996 < 0.01% $1,991,122 14 qtrs
Blackstone Inc Unchanged 2,440,330 0 < 0.01% $1,493,482 4 qtrs
Nantahala Capital Management LLC Unchanged 1,935,484 0 0.05% $1,196,807 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2025
Filed
May 15, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,157,448
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.